Evidence mapPaperPMID 38808287Full record

ArticleOpen veterinary journal2024

Hematological ratios and indices in canine large B-cell lymphoma.

Alessandra Gavazza, Valentina Cremonini, Arianna Miglio, Chiara Starita, Giacomo Rossi, Maria Teresa Antognoni

Abstract read
In one paragraph

Article in Open veterinary journal, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed.

  1. Review
  2. Article
  3. Hematological Ratios inAnimals : an open access journal from MDPI · 2026
    Article
  4. Review
  5. Article
  6. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Alessandra GavazzaSchool of Biosciences and Veterinary Medicine, University of Camerino, Matelica, Italy.
Valentina CremoniniDepartment of Veterinary Medicine, University of Perugia, Perugia, Italy.
Arianna MiglioDepartment of Veterinary Medicine, University of Perugia, Perugia, Italy.
Chiara StaritaIDEXX Laboratories Italia, Milano, Italy.
Giacomo RossiSchool of Biosciences and Veterinary Medicine, University of Camerino, Matelica, Italy.
Maria Teresa AntognoniDepartment of Veterinary Medicine, University of Perugia, Perugia, Italy.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Background: Canine lymphoma is the most common hematopoietic cancer in dogs. Numerous studies have evaluated the prognostic value of hematological abnormalities and ratios in both humans and dogs with lymphoma. Aim: To compare hematological parameters and complete blood count ratios between a population of dogs affected by lymphoma and healthy dogs to identify potential prognostic markers for lymphoma. Methods: This retrospective case-control study compares hematological parameters and complete blood count ratios between a population of 114 dogs affected by multicentric large B-cell lymphoma (LBCL) and 60 healthy dogs. Results: The study found several statistically significant differences between the hematological indices of LBCL dogs and healthy dogs, but no correlation between these parameters and the survival times of 78 dogs treated with chemotherapy Madison Wisconsin protocol. In addition, hematological alterations were evaluated such as anemia, leukocytosis, and thrombocytopenia. Conclusion: Hematological ratios have been suggested as potential prognostic markers for canine LBCL but their real prognostic value remains controversial and requires future investigation.

Indexed as

Dog DiseasesAnimalsBlood Cell CountCase-Control StudiesDogsFemaleLymphoma, B-CellLymphoma, Large B-Cell, DiffuseMalePrognosisRetrospective StudiesCBCDogsIndicesLymphomaRatios

Identifiers

PMID38808287
PMCPMC11128634

What Socratic holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.